Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies
Abstract Background Numerous vaccination research experiments have been conducted on non-primate hosts to prevent or control HTLV-1 infection. Therefore, reviewing recent advancements for status assessment and strategic planning of future preventative actions to reduce HTLV-1 infection and its conse...
Main Authors: | Niloofar Seighali, Arman Shafiee, Mohammad Ali Rafiee, Dlnya Aminzade, Sayed-Hamidreza Mozhgani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-023-08289-7 |
Similar Items
-
Editorial: Prevention and control of human T lymphotropic viruses 1 and 2 (HTLV-1/2)
by: Luiz Fernando Almeida Machado, et al.
Published: (2022-08-01) -
Radiographic aspects in individuals infected by human T-lymphotropic virus type 1 (HTLV-1) with joint pain
by: João Marcos da Silva Carvalho, et al.
Published: (2022-08-01) -
Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals
by: Karoline Rodrigues Campos, et al.
Published: (2020-10-01) -
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
by: Patrick L. Green, et al.
Published: (2010-09-01) -
The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways
by: Sahar Yaslianifard, et al.
Published: (2023-07-01)